Page 98 - ARNM-3-3

Advances in Radiotherapy
& Nuclear Medicine Cripto-1 in cancer diagnosis and therapy

Author contributions cripto. Functional and structural insights through disulfide
structure analysis. Eur J Biochem. 2003;270(17):3610-3618.
Conceptualization: Bing Wang, Lu Gan
Writing–original draft: Zhengkun Gao, Qian Li doi: 10.1046/j.1432-1033.2003.03749.x
Visualization: Ran Zheng, Jing Si, Lu Gan 9. Dono R, Scalera L, Pacifico F, Acampora D, Persico MG,
Writing – review & editing: Bing Wang, Lu Gan Simeone A. The murine cripto gene: Expression during
mesoderm induction and early heart morphogenesis.
Ethics approval and consent to participate Development. 1993;118(4):1157-1168.
Not applicable. doi: 10.1242/dev.118.4.1157
10. Ishii H, Afify SM, Hassan G, Salomon DS, Seno M. Cripto-1
Consent for publication as a potential target of cancer stem cells for immunotherapy.
Not applicable. Cancers (Basel). 2021;13(10):2491.
doi: 10.3390/cancers13102491
Availability of data
11. Rangel MC, Karasawa H, Castro NP, Nagaoka T,
Not applicable. Salomon DS, Bianco C. Role of Cripto-1 during epithelial-
to-mesenchymal transition in development and cancer. Am
References J Pathol. 2012;180(6):2188-2200.
1. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. doi: 10.1016/j.ajpath.2012.02.031
Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10-45.
12. Chu KY, Crawford AN, Krah BS, et al. Cripto-1 acts as
doi: 10.3322/caac.21871 a molecular bridge linking nodal to ALK4 via distinct
2. Alam MJ, Takahashi R, Afify SM, et al. Exogenous cripto-1 structural domains. Protein Sci. 2025;34(2):e70034.
suppresses self-renewal of cancer stem cell model. Int J Mol doi: 10.1002/pro.70034
Sci. 2018;19(11):3345.
13. Duelen R, Gilbert G, Patel A, et al. Activin A modulates
doi: 10.3390/ijms19113345 CRIPTO-1/HNF4 α+ cells to guide cardiac differentiation
3. Dela Cruz JM, Roessler E, Bamford RN, et al. Loss-of- from human embryonic stem cells. Stem Cells Int.
function mutation in the CFC domain of TDGF-1 is 2017;2017:4651238.
associated with human forebrain defects. Am J Hum Genet. doi: 10.1155/2017/4651238
2001;69(4):343-343.
14. Shafiei S, Farah O, Dufort D. Maternal Cripto is required
4. Saccone S, Rapisarda A, Motta S, Dono R, Persico GM, for proper uterine decidualization and peri-implantation
Dellavalle G. Regional localization of the human Egf-Like uterine remodeling. Biol Reprod. 2021;104(5):1045-1057.
growth-factor cripto gene (Tdgf-1) to chromosome 3p21.
Hum Genet. 1995;95(2):229-230. doi: 10.1093/biolre/ioab020

doi: 10.1007/Bf00209409 15. Stephens EB, Jackson M, Cui L, et al. Early dysregulation
of cripto-1 and immunomodulatory genes in the cerebral
5. Watanabe K, Hamada S, Bianco C, et al. Requirement of cortex in a macaque model of neuro AIDS. Neurosci Lett.
Glycosylphosphatidylinositol anchor of cripto-1 for activity 2006;410(2):94-99.
as a nodal co-receptor. J Biol Chem. 2007;282(49):35772-
35786. doi: 10.1016/j.neulet.2006.07.066
doi: 10.1074/jbc.M707351200 16. Wechselberger C, Ebert AD, Bianco C, et al. Cripto-1
enhances migration and branching morphogenesis of mouse
6. Colas JF, Schoenwolf GC. Subtractive hybridization mammary epithelial cells. Exp Cell Res. 2001;266(1):95-105.
identifies chick-cripto, a novel EGF-CFC ortholog expressed
during gastrulation, neurulation and early cardiogenesis. doi: 10.1006/excr.2001.5195
Gene. 2000;255(2):205-217. 17. Angrisano T, Varrone F, Ragozzino E, Fico A, Minchiotti G,
doi: 10.1016/S0378-1119(00)00337-1 Brancaccio M. Cripto is targeted by miR-1a-3p in a mouse
model of heart development. Int J Mol Sci. 2023;24(15):12251.
7. Iaccarino E, Sandomenico A, Corvino G, et al. Investigating
the oxidative refolding mechanism of Cripto-1 CFC domain. doi: 10.3390/ijms241512251
Int J Biol Macromol. 2019;137:1179-1189.
18. Jin JZ, Ding JX. Is required for mesoderm and endoderm
doi: 10.1016/j.ijbiomac.2019.07.040 cell allocation during mouse gastrulation. Dev Biol.
2013;381(1):170-178.
8. Foley SF, Van Vlijmen HWT, Boynton RE, et al. The
CRIPTO/FRL-1/CRYPTIC (CFC) domain of human doi: 10.1016/j.ydbio.2013.05.029

Volume 3 Issue 3 (2025) 90 doi: 10.36922/ARNM025130015